Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis

被引:0
作者
Huang, Guan-Jiang [1 ]
机构
[1] Guangzhou Univ Chinese Med, Zhongshan Hosp Tradit Chinese Med, Dept Otorhinolaryngol Head & Neck Surg, Zhongshan 528400, Guangdong, Peoples R China
关键词
D O I
10.1007/s00405-022-07394-8
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:5967 / 5968
页数:2
相关论文
共 4 条
[1]   Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review [J].
Budach, Volker ;
Tinhofer, Ingeborg .
LANCET ONCOLOGY, 2019, 20 (06) :E313-E326
[2]   Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer [J].
Fizazi, Karim ;
Shore, Neal ;
Tammela, Teuvo L. ;
Ulys, Albertas ;
Vjaters, Egils ;
Polyakov, Sergey ;
Jievaltas, Mindaugas ;
Luz, Murilo ;
Alekseev, Boris ;
Kuss, Iris ;
Kappeler, Christian ;
Snapir, Amir ;
Sarapohja, Toni ;
Smith, Matthew R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13) :1235-1246
[3]   Head and neck cancer [J].
Mody, Mayur D. ;
Rocco, James W. ;
Yom, Sue S. ;
Haddad, Robert, I ;
Saba, Nabil F. .
LANCET, 2021, 398 (10318) :2289-2299
[4]   Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study [J].
Yanni, Antoine ;
Buset, Thibaut ;
Bouland, Cyril ;
Loeb, Isabelle ;
Lechien, Jerome R. ;
Rodriguez, Alexandra ;
Journe, Fabrice ;
Saussez, Sven ;
Dequanter, Didier .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (08) :4103-4111